Utilizing the firm’s thriving life sciences offering, Morgan, Lewis & Bockius LLP is primarily active on behalf of investors and emerging companies in transactions involving the digital health, pharmaceutical, biotech, medical device, and ag-tech spheres, among others. The team is driven out of Philadelphia by Jeffrey Bodle, whose practice is geared towards advising high-growth companies, as well as seed, venture capital, and private equity investors, on the full suite of finance, capital markets, and compliance matters. Silicon Valley-based John Park serves as deputy department head; during 2023/24 he handled a string of investor-side mandates for clients such as Samsung Venture Investment Corporation and Translink Capital. In Princeton, seasoned veteran Steven Cohen contributes experience in representing entrepreneurs, private equity investors, and venture capital funds on equity financings, M&A, and securities offerings. Boston-based Julio Vega is also noted for his work on behalf of start-ups and investors in the life sciences and technology fields.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • Fanatics
  • CapitalG
  • Third Point
  • Comcast Ventures
  • G20 Ventures
  • PLEZi
  • OMERS
  • SandboxAQ
  • bloXroute Labs
  • Startup Health

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Steven Cohen

Praxisleitung

Jeffrey Bodle; John Park

Weitere Kernanwält*innen

Steven Cohen; Julio Vega; Scott Karchmer